← 홈

Antibody · VEGF

234개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 234개
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab combined with bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Bevacizumab Injection [Avastin] (Bevacizumab Injection [Avastin])

Retinal Neovascularization; Macular Edema · Retinal Neovascularization

#RetinalNeovascularization#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRochePhase 3

China-approved Bevacizumab (China-approved Bevacizumab)

Metastatic Colorectal Cancer (CRC) · Advanced Non-squamous Non-small-cell Lun

#AdvancedNon-squamousNon-small-ce#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 ACTIVE
AntibodystaleRocheApproved

Oxaliplatin;Capecitabine;Bevacizumab (Oxaliplatin;Capecitabine;Bevacizumab)

Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Approved#항체#면역항체+4
임상시험 2상태 ACTIVE
AntibodystaleRadboud University Medical Cent…Preclinical

111Indium-bevacizumab (111Indium-bevacizumab)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodySecond Affiliated Hospital, Sch…SN-38) in Cancer PatientsPhase 2

AK104 and cetuximab or bevacizumab and FOLFIRI (AK104 and cetuximab or bevacizumab and FOLFIRI)

Safety · Safety

#Safety#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodyTae Won KimPhase 2

atezolizumab (Tecentriq, Aatezolizumab plus Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

Active bevacizumab and Active dexamethasone (Active bevacizumab and Active dexamethasone)

Non-Ischemic Central Retinal Vein Occlusion · Non-Ischemic Central Retinal Vein Occlus

#Non-IschemicCentralRetinalVeinOc#Antibody#Phase3#항체#면역항체+2
효능 ORR 16.2%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyRochePhase 2

Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib (Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib)

Platinum-sensitive Relapsed Ovarian Cancer · Platinum-sensitive Relapsed Ovarian Canc

#Platinum-sensitiveRelapsedOvaria#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRegeneronPreclinical

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept [Eylea])

AMD · AMD

#AMD#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleLei LiPhase 2

Albumin-bound paclitaxel and bevacizumab (Albumin-bound paclitaxel and bevacizumab)

Ovarian Carcinoma; Platinum-resistant Ovarian Cancer · Ovarian Carcinoma

#OvarianCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Aribulin;carboplatin;bevacizumab (Aribulin;carboplatin;bevacizumab)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyRochePhase 2

atezolizumab (Tecentriq, Atezolizumab combined with bevacizumab combined with β- alanine)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab, RHUMAB VEGF (Avastin, Avastin (Bevacizumab, RHUMAB VEGF))

Rectal Cancer · Rectal Cancer

#RectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

bevacizumab, reference product (Avastin®, Avastin® (bevacizumab, reference product))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase1#항체#면역항체+2
효능 ORR 5%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Belinostat, carboplatin, paclitaxel and bevacizumab (Belinostat, carboplatin, paclitaxel and bevacizumab)

Non-Small-Cell Lung Carcinoma · Non-Small-Cell Lung Carcinoma

#Non-Small-CellLungCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleXinqiao Hospital of ChongqingPhase 2

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

NSCLC Stage IV Without EGFR/ALK Mutation · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Bevacizumab (Avastin, Bevacizumab, Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec))

Pulmonary Veno Occlusive Disease · Pulmonary Veno Occlusive Disease

#PulmonaryVenoOcclusiveDisease#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

2 / 12 페이지

← 이전다음 →